Pharma Industry News

Interventional Spine Announces its 75th Patient Treated with the PerX360 Percutaneous Spinal Fusion Technology

IRVINE, Calif., Aug. 22, 2012 /PRNewswire/ -- Interventional Spine, Inc. today announced that after having obtained clearance from the FDA , it has successfully completed 75 implants worldwide using the PerX360 Percutaneous Lumbar Fusion System for the treatment of Degenerative...


Taxonomy upgrade extras: 

Legemidler Direkte På Døren! 121doc - En Av Norges Ledende Online Klinikker

LONDON, August 22, 2012 /PRNewswire/ -- 121doc startet opp I 2004 og har siden da vokst til a bli ett av markedets ledende online apotek. Nokkelord som beskriver var bedrift effektivitet, diskresjon og sikkerhet, da vi tilbyr leveranse innen 48 timer og diskret innpakning...
Taxonomy upgrade extras: 

Elsevier / Gold Standard Announces New Drug Class Overviews for Clinical Pharmacology

TAMPA, Florida, August 22, 2012 /PRNewswire/ -- Drug Class Overviews revamped to address the changing needs of health care professionals Leading drug information provider Elsevier / Gold Standard announced today its new Drug Class Overviews, making Clinical Pharmacology more valuable at...
Taxonomy upgrade extras: 

Physicians' Capital Investments, Physicians' Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative

DALLAS, Aug. 21, 2012 /PRNewswire-iReach/ -- Physicians' Capital Investments, LLC (PCI), a leader in medical real estate development and medical investment solutions, Physicians' Capital Markets, LLC (PCM), a leader in innovative capital formation solutions, are pleased to announce a...
Taxonomy upgrade extras: 

Axiom Worldwide Delists and Terminates US FDA 510(k)s for the DRX9000 Series of Products

TAMPA, Fla., Aug. 21, 2012 /PRNewswire-iReach/ -- On August 20th, 2012, Mr. James Gibson, President & CEO of Axiom Worldwide, Inc. offered further clarification regarding the status of Axiom's US FDA 510(k)s. Although Axiom Worldwide, Inc. still maintains ownership of its Intellectual...


Taxonomy upgrade extras: 

CaloSpa Rejuvenation Center hosts Beverly Hills in the Ville with pioneer skin care expert, Dr. Zein Obagi at The Palace Theatre

LOUISVILLE, Ky., Aug. 21, 2012 /PRNewswire-iReach/ -- As an exclusive provider of the new skin care lines ZO Medical and ZO Skin Health by internationally renowned expert, Dr. Zein Obagi, MD., board-certified plastic surgeons, Dr. Bradley Calobrace and Dr. Nana Mizuguchi of CaloSpa...
Taxonomy upgrade extras: 

Alexza Pharmaceuticals Receives EU Certificate of GMP Compliance for its ADASUVE™ Manufacturing Facility

MOUNTAIN VIEW, Calif., Aug. 21, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the company has received its EU Certificate of GMP Compliance of a Manufacturer. In May 2012, Alexza hosted an EU GMP inspection, which was conducted by the Agencia...
Taxonomy upgrade extras: 

Senator Blumenthal, a Strong Advocate for Women's Health, Visits Hologic's Manufacturing Facility in Danbury, CT

BEDFORD, Mass., Aug. 21, 2012 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) announced that today it hosted Senator Richard Blumenthal (D-Conn.) and Rep. Chris Murphy (D-CT 5) at the Company's women's imaging manufacturing facility in Danbury, CT. The Senator and Representative...
Taxonomy upgrade extras: 

Kewaunee Scientific Reports Improved Sales and Earnings for First Quarter

STATESVILLE, N.C., Aug. 21, 2012 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its first quarter ended July 31, 2012. Net earnings for the quarter were $634,000, or $0.25 per diluted share, up from net earnings of $22,000, or $0.01...
Taxonomy upgrade extras: 

Transcept Pharmaceuticals Announces Listing of New U.S. Patent for Intermezzo in FDA's Orange Book

POINT RICHMOND, Calif., Aug. 21, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that the U.S. Food and Drug Administration has listed U.S. Patent No. 8,242,131 (the '131 patent) in its Approved Drug Products with Therapeutic Equivalence Evaluations, or...


Taxonomy upgrade extras: 

Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research

FARMINGTON, Conn., Aug. 21, 2012 /PRNewswire-iReach/ -- Epigenomics is a potential game-changer in the clinical therapeutics and testing markets. From understanding the exosomes involved in the cell migrations characteristic of cancer metastasis to analyzing microRNA expressions, the...


Taxonomy upgrade extras: 

New England Biolabs, Inc. achieves ISO 14001 recertification in recognition of its commitment to environmental management

IPSWICH, Mass., Aug. 21, 2012 /PRNewswire/ -- New England Biolabs, a world leader in the production and supply of reagents for the life science industry, today announced it has received ISO 14001 recertification in recognition of the Company's constant dedication to, and outstanding...


Taxonomy upgrade extras: